RBC Capital Downgrades Ultragenyx Pharma (RARE) to Sector Perform

September 3, 2026 7:28 AM

RBC Capital analyst Luca Issi downgraded Ultragenyx Pharma (NASDAQ: RARE) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found